1 ANNEX  
 
Annex VI is amended as follows:  
(1) The introductory  paragraphs  are replaced by the following:   
"Part 1 of this Annex provides an introduction to the list of harmonised classification and 
labelling, including information listed for each entry and re lated classifications and hazard 
statements in Table 3.  
Part 2 of this Annex lays down general principles for preparing dossiers to propose and justify 
harmonised classification and labelling of substances at Union  level.  
Part 3 of this Annex lists hazar dous substances for which harmonised classification and 
labelling have been established at Union  level. In Table 3 the classification and labelling are 
based on the criteria in Annex I to this Regulation. ";  
(2) Part 1 is amended as follows:  
(a) The title of Section 1.1.2 . is replaced by the following:  
"Information related to the classification and labelling of each entry in Table 3 "; 
(b) Section 1.1.2.3  is replaced by the following :  
"1.1.2.3. Specific concentration limits, M -factors and Acute Toxicity Est imates (ATE)  
Specific  concentration limits, where different from the generic concentration limits given in 
Annex I for a certain category, are given in a separate column together with the classification 
concerned using the same codes as under 1.1.2.1.1. Wh ere no specific concentration limits are 
given in this Annex for a certain category, the generic concentration limits given in Annex I 
must be applied for the classification of substances containing impurities, additives or 
individual constituents or for m ixtures.  
Unless otherwise shown, the concentration limits are a percentage by weight of the substance 
calculated with reference to the total weight of the mixture.  
In case an M -factor has been harmonised for substances classified as hazardous to the aqua tic 
environment in the categories Aquatic Acute 1 or Aquatic Chronic 1, that M-factor is given in 
Table 3 in the same column as the specific concentration limits. In case an M - factor for 
Aquatic Acute 1 and an M -factor for Aquatic Chronic 1 have been harm onised, each M -factor 
shall be listed in the same line as its corresponding differentiation. Where a single M -factor is 
given in Table 3 and the substance is classified as Aquatic Acute 1 and Aquatic Chronic 1, 
that M-factor shall be used by the manufactur er, importer or downstream user for the 
classification of a mixture containing this substance for acute and long -term aquatic hazards 
using the summation method. Where no M -factor is given in Table 3, M -factor(s) based on 
available data for the substance s hall be set by the manufacturer, importer or downstream 
user. For the setting and use of M -factors, see section 4.1.3.5.5.5 of Annex I. "; 
(c) the following paragraph is added to section 1.1.2.3.:  2 
 "Harmonised ATEs are given in Table 3 in the same column as  the SCLs and M -Factors. 
These ATEs shall be used by the manufacturer, importer or downstream users for the 
classification of a mixture containing this substance.";  
(d) Section 1.1.3 . is amended as follows:  
(i) Note E is deleted ; 
(ii) Note K  is replaced by  the following:  
"The classification as a carcinogen or mutagen need not apply if it can be shown that 
the substance contains less than 0,1 % w/w 1,3 - butadiene (EINECS No 203 -450-8). If 
the substance is not classified as a carcinogen or mutagen, at least t he precautionary 
statements (P102 -)P210 -P403 (Table 3) should apply. This note applies only to certain 
complex oil -derived substances in Part 3 ."; 
(iii) Note P  is replaced by the following : 
"The classification as a carcinogen or mutagen need not apply if i t can be shown that 
the substance contains less than 0,1 % w/w benzene (EINECS No 200 -753-7).  
When the substance is not classified as a carcinogen at least the precautionary 
statements (P102 -)P260 -P262 -P301 + P310 -P331 (Table 3) shall apply.  
This note ap plies only to certain complex oil -derived substances in Part 3. "; 
(iv) Note S  is replaced by the following:  
"This substance may not require a label according to Article 17 (see section 1.3 of   
 Annex I) (Table 3)." ;  
 
(v) In Note U , the title is replaced by the following:  
"Note U ( Table 3 ):"; 
(vi) In section 1.1.3.2., Note 1  is replaced by the following:  
"The concentration stated or, in the absence of such concentrations, the generic 
concentrations set out in this Regulation are the percentages by weight o f the metallic 
element calculated with reference to the total weight of the mixture." ; 
(e) Section 1.1.4 . is deleted ; 
(3) Part 3 is amended as follows:  
(a) The introductory paragraph s are deleted .  
(b) The title of Table 3.1 is replaced by the following:   
"Table 3   
List of harmonised classification and labelling of hazardous substances "; 3 
  
 1 (c) Table 3 is amended as follows:  
 (i) The title of the penultimate column  is replaced by " Specific Conc. Limits, M - factors  and A cute Toxicity Estimates (ATE) "; 
(ii) The entries corresponding to index numbers 006-046-00-8, 604 -057-00-8, 605 -023-00-5, 606 -041-00-6, 607 -123-00-4, 608 -055-00-
8, 612 -150-00-X, 613 -318-00-5, 614 -001-00-4, 615 -013-00-2, 616 -006-00-7, 616 -094-00-7 and 650-032-00-X are replaced by the 
followin g corresponding entries : 
" 
Index No  International Chemical 
Identification  EC No  CAS No  Classification  Labelling  Specific Conc. 
Limits, M - 
factors  and ATE  Notes  
Hazard Class and 
Category Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal Word   
Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement 
Code(s)  
006-046-00-8 bendiocarb (ISO);  
2,2-dimethyl -1,3-benzodioxol -4-
yl N-methylcarbamate;  
2,2-dimethyl -1,3-benzodioxol -4-
yl methylcarbamate  245-216-8 22781 -23-3 Acute Tox. 3  
Acute Tox. 3  
Acute Tox. 2 
Aquatic Acute 1  
Aquatic Chronic 1  H331  
H311  
H300  
H400  
H410  GHS06  
GHS09  
Dgr H331  
H311  
H300  
H410    
 
 
M=10  
M=100   
604-057-00-8 reaction mass of: isomers of 2 -
(2H-benzotriazol -2-yl)-4-
methyl -(n)-dodecylphenol; 
isomers of 2 -(2H-benzotriazol -
2-yl)-4-methyl -(n)-
tetracosylphenol; isomers of 2 -
(2H-benzotriazol -2-yl)-4-
methyl -5,6-didodecyl -phenol. n 
= 5 or 6  401-680-5 - Aquatic Chronic 4  H413   H413     
605-023-00-5 
 5-chloro -2-(4-
chlorophenoxy)phenol;  
[DCPP]  429-290-0 3380 -30-1 Eye Dam. 1  
Aquatic Acute 1  
Aquatic C hronic 1  H318  
H400  
H410  GHS05  
GHS09  
Dgr H318  
H410    
M=10  
M=10   
606-041-00-6 2-methyl -1-(4-
methylthiophenyl) -2-
morpholinopropan -1-one 400-600-6 71868 -10-5 Repr. 1B  
Acute Tox. 4 *  
Aquatic Chronic 2  
 H360FD  
H302  
H411  
 GHS08  
GHS07  
GHS09  
Dgr H360FD  
H302  
H411 
    
607-123-00-4 2,3-epoxypropyl methacrylate;  
glycidyl methacrylate  203-441-9 106-91-2 Carc. 1B  
Muta. 2  
Repr. 1B  
Acute Tox. 3  
Acute Tox. 4  
STOT SE 3  H350  
H341  
H360F  
H311  
H302  
H335  GHS08  
GHS06  
GHS05  
Dgr 
 H350  
H341  
H360F  
H311  
H302  
H335    D 2 
 Index No  International Chemical 
Identification  EC No  CAS No  Classification  Labelling  Specific Conc. 
Limits, M - 
factors  and ATE  Notes  
Hazard Class and 
Category Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal Word   
Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement 
Code(s)  
STOT RE 1  
Eye Dam. 1  
Skin Corr. 1C  
Skin Sens. 1  
 H372 
(respiratory 
tract) 
(inhalation)  
H318  
H314  
H317  
 H372 
(respiratory 
tract) 
(inhalation)  
H314  
H317  
 
608-055-00-8 fipronil (ISO);  
(±)-5-amino -1-(2,6-dichloro -
α,α,α -trifluoro -para -tolyl) -4-
trifluoromethylsulfinyl -
pyrazole -3-carbonitrile  
 424-610-5 120068 -37-3 Acute Tox. 3*  
Acute Tox. 3*  
Acute Tox. 3*  
STOT RE 1  
Aquatic Acute 1  
Aquatic Chronic 1  H301  
H311  
H331  
H372*  
H400  
H410  GHS06  
GHS08  
GHS09  
Dgr H301  
H311  
H331  
H372*  
H410    
 
 
 
M=1000  
M=10000   
612-150-00-X spiroxamin e (ISO);  
8-tert-butyl -1,4-
dioxaspiro[4.5]decan -2-
ylmethyl(ethyl)(propyl)amine  - 118134 -30-8 Repr. 2  
Acute Tox. 4  
Acute Tox. 4  
Acute Tox. 4  
STOT RE 2  
Skin Irrit. 2 
Skin Sens. 1  
Aquatic Acute 1  
Aquatic Chronic 1  H361d  
H332  
H312  
H302  
H373 (eye)  
H315  
H317  
H400 
H410  GHS08  
GHS07  
GHS09  
Wng  H361d  
H332  
H312  
H302  
H373 (eye)  
H315  
H317  
H410    
 
 
 
 
 
 
M=100  
M=100   
613-318-00-5 fenpyrazamine (ISO);  
S-allyl 5 -amino -2,3-dihydro -2-
isopropyl -3-oxo-4-(o-
tolyl)pyrazole -1-carbothioate;  
S-allyl 5 -amino -2-isopropyl -4-
(2-methy lphenyl) -3-oxo-2,3-
dihydropyrazole -1-carbothioate  
 - 473798 -59-3 Aquatic Acute 1 
Aquatic Chronic 1  H400  
H410  GHS09  
Wng  H410   M=10  
M=1   
614-001-00-4 nicotine (ISO);  
3-[(2S) -1-methylpyrrolidin -2-
yl]pyridine  200-193-3 54-11-5 Acute Tox. 2  
Acute Tox. 2  
Acut e Tox. 2  
Aquatic Chronic 2  H330  
H310  
H300  
H411  GHS06  
GHS09  
Dgr H330  
H310  
H300  
H411   inhalation :  
ATE = 0.19 
mg/L  (dust s or 
mists)  
dermal :  
ATE  = 70 mg/kg  
oral:  
ATE1 = 5 mg/kg   
                                                 
1 Converted acute toxicity point estimate a ccording to Table 3.1.2 of Annex I .  3 
 Index No  International Chemical 
Identification  EC No  CAS No  Classification  Labelling  Specific Conc. 
Limits, M - 
factors  and ATE  Notes  
Hazard Class and 
Category Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal Word   
Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement 
Code(s)  
615-013-00-2 cyanamide;  
carbamonitril  206-992-3 420-04-2 Carc. 2  
Repr. 2  
Acute Tox. 3  
Acute Tox. 3  
STOT RE 2  
Skin Corr. 1  
Skin Sens. 1  
Aquatic Chronic 3  H351  
H361fd  
H311  
H301  
H373 (thyroid)  
H314  
H317  
H412  GHS08  
GHS06  
GHS05  
Dgr H351  
H361fd  
H311  
H301  
H373 
(thyroid)  
H314  
H317  
H412     
616-006-00-7 dichlofluanid (ISO);  
N-[(dichloroflu oromethyl)thio] -
N',N' -dimethyl -N-
phenylsulfamide  214-118-7 1085 -98-9 Acute Tox. 4  
Eye Irrit. 2  
Skin Sens. 1  
Aquatic Acute 1  H332  
H319  
H317  
H400  GHS07  
GHS09  
Wng  H332  
H319  
H317  
H400    
 
 
M=10   
616-094-00-7 
 3,3'-dicyclohexyl -1,1'-
methylenebis(4,1 -
phenylene)d iurea  406-370-3 58890 -25-8 Aquatic Chronic 4  
 H413  
  H413  
    
650-032-00-X 
 cyproconazole (ISO); 
(2RS,3RS;2RS,3SR) -2-(4-
chlorophenyl) -3-cyclopropyl -1-
(1H-1,2,4 -triazol -1-yl)butan -2-
ol - 94361 -06-5 Repr. 1B  
Acute Tox. 3  
STOT RE 2  
Aquatic Acute 1  
Aquatic Ch ronic 1  H360D  
H301  
H373 (liver)  
H400  
H410  GHS08  
GHS06  
GHS09  
Dgr H360D  
H301  
H373 (liver)  
H410    
 
 
M=10  
M=1   
 
". 
(iii) The following entries are inserted in accordance with the order of the entries set out in Table 3 : 
" 
 
Index No  International Chemical 
Iden tification  EC No  CAS No  Classification  Labelling  Specific Conc. 
Limits, M - 
factors  Notes  
Hazard Class and 
Category Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal Word   
Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement 
Code(s)  
047-003-00-3 silver zinc zeolite (Zeolite, LTA 
framework type, surface -
modified with silver and zinc 
ions)  - 
 130328 -20-0 Repr. 2  
Skin Irrit. 2  
Eye Dam. 1  
Aquatic Acute 1  H361d  
H315  
H318  
H400  GHS08  
GHS05  
GHS09  
Dgr H361d  
H315  
H318  
H410    
 
 
M=100   4 
 Index No  International Chemical 
Iden tification  EC No  CAS No  Classification  Labelling  Specific Conc. 
Limits, M - 
factors  Notes  
Hazard Class and 
Category Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal Word   
Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement 
Code(s)  
 
[This entry covers LTA ( Linde 
Type A) framework type zeolite 
which has been surface -
modified with both silver and 
zinc ions at contents Ag+ 0.5% -
6%, Zn2+ 5% -16%, and 
potentially with phosphorus, 
NH4+, Mg2+ and/or Ca2+ each 
at level <3%]  
 Aquatic Chronic 1  H410  M=100  
048-012-00-5 cadmium carbonate  208-168-9 513-78-0 Carc. 1B  
Muta. 1B  
Acute Tox. 4 *  
Acute Tox. 4 *  
Acute Tox. 4 *  
STOT RE 1  
Aquatic Acute 1  
Aquatic Chronic 1  
 H350  
H340  
H332  
H312  
H302  
H372 (kidney, 
bone)  
H400  
H410  
 
 GHS08  
GHS07  
GHS09  
Dgr H350  
H340  
H332  
H312  
H302 
H372 (kidney, 
bone)  
H410  
 
   A1 
048-013-00-0 cadmium hydroxide; cadmium 
dihydroxide  244-168-5 21041 -95-2 Carc. 1B  
Muta. 1B  
Acute Tox. 4 *  
Acute Tox. 4 *  
Acute Tox. 4 *  
STOT RE 1  
Aquatic Acute 1  
Aquatic Chronic 1  
 H350  
H340  
H332  
H312  
H302  
H372 (kidney,  
bone)  
H400  
H410  
 
 GHS08  
GHS07  
GHS09  
Dgr H350  
H340  
H332  
H312  
H302  
H372 (kidney, 
bone)  
H410  
 
   A1 
048-014-00-6 cadmium nitrate;  
cadmium dinitrate  233-710-6 10325 -94-7 
 Carc. 1B  
Muta. 1B  
Acute Tox. 4 *  
Acute Tox. 4 *  
Acute Tox. 4 *  
STOT RE 1  
Aquatic Ac ute 1  
Aquatic Chronic 1  
 H350  
H340  
H332  
H312  
H302  
H372 (kidney, 
bone)  
H400  
H410  
 GHS08  
GHS07  
GHS09  
Dgr H350  
H340  
H332  
H312  
H302  
H372 (kidney, 
bone)  
H410  
 
  Carc. 1B; H350:  
C ≥ 0.01%  A1 5 
 Index No  International Chemical 
Iden tification  EC No  CAS No  Classification  Labelling  Specific Conc. 
Limits, M - 
factors  Notes  
Hazard Class and 
Category Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal Word   
Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement 
Code(s)  
 
050-030-00-3 dibutyltin dilaurate; 
dibutyl[bis(dodecanoyloxy)]sta
nnane  201-039-8 77-58-7 Muta. 2  
Repr. 1B  
STOT RE 1  H341  
H360FD  
H372 (immune 
system)  GHS08  
Dgr H341  
H360FD  
H372 
(immune 
system)     
603-235-00-2 linalool; 3,7 -dimethyl -1,6-
octadi en-3-ol; dl -linalool; [1]  
coriandrol; (S) -3,7-dimethyl -
1,6-octadien -3-ol; d -linalool; [2]  
licareol; (R) -3,7-dimethyl -1,6-
octadien -3-ol; l-linalool [3]  201-134-4 
[1] 
204-810-7 
[2] 
204-811-2 
[3] 78-70-6 [1]  
126-90-9 [2]  
126-91-0 [3]  Skin Sens. 1B  
 H317  GHS07  
Wng  
 H317     
604-093-00-4 clorofene;  
chlorophene;  
2-benzyl -4-chlorophenol  204-385-8 120-32-1 Carc. 2  
Repr. 2  
Acute Tox. 4  
Skin Irrit. 2  
Skin Sens. 1  
Eye Dam. 1  
STOT RE 2  
Aquatic Acute 1  
Aquatic Chronic 1  H351  
H361f  
H332  
H315  
H317  
H318  
H373 (kidney)  
H400 
H410  GHS08  
GHS05  
GHS07  
GHS09  
Dgr H351  
H361f  
H332  
H315  
H317  
H318  
H373 (kidney)  
H410    
 
 
 
 
 
 
M=1  
M=100   
606-150-00-9 clethodim (ISO); (5RS) -2-
{(1EZ) -1-[(2E) -3-
chloroallyloxyimino]propyl} -5-
[(2RS) -2-(ethylthio)propyl] -3-
hydroxycyclohex -2-en-1-one - 99129 -21-2 Acute Tox. 4  
Skin Sens. 1  
Aquatic Chronic 3  H302  
H317  
H412  GHS07  
Wng  H302  
H317  
H412  EUH066    
606-151-00-4 anthraquinone  201-549-0 84-65-1 Carc. 1B  H350  GHS08  
Dgr H350     
607-720-00-X nonadecafluorodecanoic acid; 
[1] 
ammonium 
nonadecafluorodecanoate; [2]  
sodium 
nonadecafluorodecanoate [3]  206-400-3 
[1] 221 -
470-5 [2]  
- [3] 335-76-2 [1] 
3108 -42-7 [2]  
3830 -45-3 [3]  Carc. 2  
Repr. 1B  
Lact.  
 H351  
H360Df  
H362  
 GHS08  
Dgr H351  
H360Df  
H362  
    
607-721-00-5 N,N' -methylenedimorpholine;  
N,N' -methylenebismorpho line;  
 
[formaldehyde released from 
N,N' -methylenebismorpholine];  
 
[MBM]  227-062-3 5625 -90-1 Carc. 1B  
Muta. 2  
Acute Tox. 4  
Acute Tox. 4  
Acute Tox. 4  
STOT RE 2  
Skin Corr. 1B  
Skin Sens. 1  H350  
H341  
H332  
H312  
H302  
H373 
(gastrointestin
al tract, GHS08  
GHS07  
GHS05  
Dgr H350  
H341  
H332  
H312  
H302  
H373 
(gastrointestin
al tract, EUH071    6 
 Index No  International Chemical 
Iden tification  EC No  CAS No  Classification  Labelling  Specific Conc. 
Limits, M - 
factors  Notes  
Hazard Class and 
Category Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal Word   
Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement 
Code(s)  
 
 
 
 
 respirato ry 
tract)  
H314  
H317  
 respiratory 
tract)  
H314  
H317  
 
607-722-00-0 2,3,5,6 -tetrafluoro -4-
(methoxymethyl)benzyl (Z) -
(1R,3R) -3-(2-cyanoprop -1-
enyl) -2,2-
dimethylcyclopropane carboxyl
ate;  
epsilon -momfluorothrin   - 1065124 -65-3 Acute Tox. 4  
STOT SE 2  
Aquatic Acute 1  
Aquatic Chronic 1  H302  
H371 (nervous 
system)  
H400  
H410  GHS07  
GHS08  
GHS09  
Wng  H302  
H371 
(nervous 
system)  
H410    
 
M=100  
M=100   
607-723-00-6 tefluthrin (ISO);  
2,3,5 ,6-tetrafluoro -4-
methylbenzyl (1RS,3RS) -3-[(Z)-
2-chloro -3,3,3 -trifluoroprop -1-
enyl] -2,2-
dimethylcyclopropanecarboxyl
ate - 79538 -32-2 Acute Tox. 1  
Acute Tox. 2  
Acute Tox. 2  
Aquatic Acute 1  
Aquatic Chronic 1  
 H330  
H310  
H300  
H400  
H410  GHS06  
GHS09  
Dgr H330   
H310  
H300  
H410  
   
 
 
M=10000  
M=10000   
612-290-00-1 reaction products of 
paraformaldehyde and 2 -
hydroxypropylamine (ratio 
3:2);  
 
[formaldehyde released from 
3,3'-methylenebis[5 -
methyloxazolidine]  
formaldehyde released from 
oxazolidin];  
 
[MBO]  - - Carc.  1B  
Muta. 2  
Acute Tox. 4  
Acute Tox. 3  
Acute Tox. 4  
STOT RE 2  
Skin Corr. 1B  
Eye Dam. 1  
Skin Sens. 1A  
Aquatic Chronic 2  H350  
H341  
H332  
H311  
H302  
H373 
(gastrointestin
al tract, 
respiratory 
tract)  
H314  
H318  
H317  
H411  GHS08  
GHS06  
GHS05  
GHS09  
Dgr H350  
H341  
H332  
H311  
H302  
H373 
(gastrointestin
al tract, 
respiratory 
tract)  
H314  
 
H317  
H411  EUH071    
612-291-00-7 reaction products of 
paraformaldehyde with 2 -
hydroxypropylamine (ratio 
1:1);  
 
[formaldehyde released from 
α,α,α -trimethyl -1,3,5 -triazine -
1,3,5(2H,4H,6H) -triethanol];  
 
[HPT]  - - Carc. 1B  
Muta. 2  
Acute Tox. 4  
Acute Tox. 4  
STOT RE 2  
Skin Corr. 1C  
Eye Dam. 1  
Skin Sens. 1A  
Aquatic Chronic 2  H350  
H341  
H332  
H302  
H373 
(gastrointestin
al tra ct, 
respiratory 
tract)  
H314  GHS08  
GHS07  
GHS05  
GHS09  
Dgr H350  
H341  
H332  
H302  
H373 
(gastrointestin
al tract, 
respiratory 
tract)  
H314  EUH071    7 
 Index No  International Chemical 
Iden tification  EC No  CAS No  Classification  Labelling  Specific Conc. 
Limits, M - 
factors  Notes  
Hazard Class and 
Category Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal Word   
Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement 
Code(s)  
H318  
H317  
H411  H317  
H411  
612-292-00-2 methylhydrazine  200-471-4 60-34-4 Carc. 1B  H350  GHS08  
Dgr H350  
    
613-321-00-1 (RS) -4-[1-(2,3-
dimethylphenyl)ethyl] -1H-
imidazole;  
medetomidine  - 86347 -14-0 Acute Tox. 2  
Acute Tox. 2  
STOT SE 3  
STOT SE 1  
STOT RE 1  
Aquatic Acute 1  
Aquatic Chronic 1  H330  
H300  
H336  
H370 (eye)  
H372  
H400  
H410  GHS06  
GHS08  
GHS09  
Dgr H330  
H300  
H336  
H370 (eye)  
H372  
H410    
 
 
 
 
M=1  
M=100   
613-322-00-7 triadimenol (ISO); 
(1RS,2RS;1RS,2SR) -1- 
(4-chlorophenoxy) -3,3- 
dimethyl -1-(1H-1,2,4 - 
triazol -1-yl)butan -2-ol; 
α-tert-butyl -β-(4-
chlorophenoxy) -1H-1,2,4 -
triazole -1-ethanol  259-537-6 55219 -65-3 Repr. 1B  
Lact.  
Acute Tox. 4  
Aquatic Chronic 2  H360  
H362  
H302  
H411  GHS08  
GHS07  
GHS09  
Dgr H360  
H362  
H302  
H411     
613-323-00-2 terbuthylazine (ISO);  
N-tert-butyl -6-chloro -N'-ethyl -
1,3,5 -triazine -2,4-diamine  227-637-9 5915 -41-3 Acute Tox. 4  
STOT RE 2  
Aquatic Acute 1  
Aquatic Chronic 1  H302  
H373  
H400  
H410  GHS07  
GHS08  
GHS09  
Wng  H302  
H373  
H410    
 
M=10  
M=10   
613-324-00-8 quinolin -8-ol;  
8-hydroxyquinoline  205-711-1 148-24-3 Repr. 1B  
Acute Tox. 3  
Eye Dam. 1  
Skin Sens. 1  
Aquatic Acute 1  
Aquatic Chronic 1  H360D  
H301  
H318  
H317  
H400  
H410 GHS08  
GHS06  
GHS05  
GHS09  
Dgr 
 H360D  
H301  
H318  
H317  
H410    
 
 
 
M=1  
M=1   
613-325-00-3 thiacloprid (ISO);  
(Z)-3-(6-chloro -3-
pyridylmethyl) -1,3-thiazolidin -
2-ylidenecyanamide;  
{(2Z) -3-[(6-chloropyridin -3-
yl)methyl] -1,3-thiazolidin -2-
ylidene}cyanamide  - 111988-49-9 Carc. 2  
Repr. 1B  
Acute Tox. 4  
Acute Tox. 3  
STOT SE 3  
Aquatic Acute 1  
Aquatic Chronic 1  H351  
H360FD  
H332  
H301  
H336  
H400  
H410  GHS08 
GHS06  
GHS09  
Dgr H351  
H360FD  
H332  
H301  
H336  
H410    
 
 
 
 
M=100  
M=100   
616-221-00-6 hexaflumuron (ISO);  
1-(3,5-dichloro -4-(1,1,2,2 -
tetrafluoroethoxy)phenyl) -3-
(2,6-difluorobenzoyl)urea  401-400-1 86479 -06-3 Aquatic Acute 1  
Aquatic Chronic 1  H400  
H410  GHS09  
Wng  H410   M=1000  
M=10000   8 
 Index No  International Chemical 
Iden tification  EC No  CAS No  Classification  Labelling  Specific Conc. 
Limits, M - 
factors  Notes  
Hazard Class and 
Category Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal Word   
Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement 
Code(s)  
616-222-00-1 penthiopyrad (ISO);  
(RS) -N-[2-(1,3-dimethylbutyl) -
3-thienyl] -1-methyl -3-
(trifluoromethyl)pyrazole -4-
carboxamide  - 183675 -82-3 Aquatic Acute 1  
Aquatic Chronic 1  H400  
H410  GHS09  
Wng  H410   M=1  
M=1   
616-223-00-7 carbetamide (ISO);  
(R)-1-(ethylcarbamoyl)ethyl 
carbanilate; (2R) -1-
(ethylamino) -1-oxopropan -2-yl 
phenylcarbam ate 240-286-6 16118 -49-3 Carc. 2  
Repr. 1B  
Acute Tox. 4  
Aquatic Chronic 2  H351  
H360D  
H302  
H411  GHS08  
GHS07  
GHS09  
Dgr H351  
H360D  
H302  
H411     
 ".